Nykode Therapeutics AS (VACBF PINK) stock market data APIs
$0.1892
0(0%)
as of December 23, 2025
Try our APIs with
free plan!
Nykode Therapeutics AS Financial Data Overview
Price chart is built with
Anychart
Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases. The company develops vaccines for the treatment cancer, autoimmune, and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of locally advanced and metastatic tumors; and VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer. Nykode Therapeutics AS was founded in 2006 and is headquartered in Oslo, Norway.
Prev. Close
0.1892
Open
0.1892
High
0.1892
Low
0.1892
52 wk Range
0.124-0.315
Market Cap
72 614 K
Shares Outstanding
327 M
Revenue
7 346 K
EPS
-0.0112
Dividends (Yield)
0.4681
Beta
1.165
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Nykode Therapeutics AS data using free add-ons & libraries
Get Nykode Therapeutics AS Fundamental Data
Nykode Therapeutics AS Fundamental data includes:
- Net Revenue: 7 346 K
- EBITDA: -25 750 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-24
- EPS/Forecast: -0.25
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Nykode Therapeutics AS News
New
European Penny Stocks To Watch In November 2025
Amidst renewed concerns over inflated AI stock valuations, European markets have experienced a downturn, with the pan-European STOXX Europe 600 Index declining by 2.21%. Despite these broader market c...
Corporacion America Airports SA (CAAP) Q3 2025 Earnings Call Highlights: Record Profitability ...
This article first appeared on GuruFocus. Release Date: November 24, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Passe...
Spotlight On 3 European Penny Stocks With Market Caps Larger Than €20M
As European markets experience a pullback from recent highs amid political turmoil and international trade tensions, investors are increasingly looking for opportunities in less traditional areas of t...
Uncovering Opportunities: I.M.D. International Medical Devices And 2 More European Penny Stocks
As the European market experiences a modest rise, with major indices like Italy's FTSE MIB and France's CAC 40 showing notable gains, investors are keenly observing opportunities amid stable interest ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
